NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
Active Not RecruitingPhase 2
Sponsor: Bluefin Biomedicine, Inc.
Conditions: Atopic Dermatitis (AD)
Interventions: BFB759, Placebo
Countries: United States, Bulgaria, Canada, Czechia, Germany, Poland, Spain
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.
Eligibility overview
Sex: ALL
Age: 18 Years to 75 Years
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: * Are adults (18-75) with a diagnosis of atopic dermatitis for at least one year. * Have moderate to severe disease not adequately controlled by topical treatments. * Are willing to follow study instructions, attend regular visits, and avoid certain other medications during the study. Exclusion Criteria: * Have certain infections or other immune conditions. * Recently used medications that could interfere with the study. * Are pregnant or breastfeeding.
Locations (88)
- Phoenix, Arizona, United States
- Phoenix, Arizona, United States
- Encino, California, United States
- Huntington Beach, California, United States
- Lancaster, California, United States
- Los Angeles, California, United States
- Rocklin, California, United States
- West Hills, California, United States
- Boca Raton, Florida, United States
- Coral Gables, Florida, United States
- Fort Lauderdale, Florida, United States
- Margate, Florida, United States
- North Miami Beach, Florida, United States
- Sweetwater, Florida, United States
- Tampa, Florida, United States
- Winter Park, Florida, United States
- Douglasville, Georgia, United States
- Douglasville, Georgia, United States
- Plainfield, Indiana, United States
- Covington, Louisiana, United States
- Metairie, Louisiana, United States
- Brighton, Massachusetts, United States
- Auburn Hills, Michigan, United States
- Northville, Michigan, United States
- Saint Joseph, Missouri, United States
- Missoula, Montana, United States
- Las Vegas, Nevada, United States
- Reno, Nevada, United States
- Reno, Nevada, United States
- Sparks, Nevada, United States
- + 58 more on CT.gov